Panencephalitis, Subacute Sclerosing

Watchlist

(log in to enable)

Retrieved

2019-09-22

Source

Omim

Trials

—

Genes

MYOM2, MYBPH, MX1, CD46, IFNG, SPATA2, IL10, IRF1, IL4, IL2, HLA-A, IL17A, CD38, PDCD1, SNCA, TIMP1, TLR3, AGTR1, TLR4, TNF, SCN1A, GNLY, IL22, IL23A, NECTIN4, IL17F, IFNL3, IFNL1, SDC1, MMP9

MYOM2, MYBPH, MX1, CD46, IFNG, SPATA2, IL10, IRF1, IL4, IL2, HLA-A, IL17A, CD38, PDCD1, SNCA, TIMP1, TLR3, AGTR1, TLR4, TNF, SCN1A, GNLY, IL22, IL23A, NECTIN4, IL17F, IFNL3, IFNL1, SDC1, MMP9, RPL17, IFNA2, ACE, EDN1, EDNRA, GCG, GLO1, GZMB, IFNB1, PYCR1, IL6, IL12B, IL12RB1, IL18, LBR, PGM3, RPL17-C18orf32

Drugs

—

Interested in hearing about new therapies?

Bartram et al. (1982) observed subacute sclerosing panencephalitis in a brother and sister of nonconsanguineous parents of 11 children living in rural Turkey. An interval of 4 years separated onset of symptoms in the 2 children. Fibroblast interferon had no beneficial effect.